Vicarious Surgical Inc.
NYSE:RBOT
8.4 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 3.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.524 | 0.521 | 0.525 | 0.447 | 0.641 | 0.637 | 0.595 | 0.539 | 0.186 | 0.185 | 0.126 | 0.084 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.524 | -0.521 | 2.925 | -0.447 | -0.641 | -0.637 | -0.595 | -0.539 | -0.186 | -0.185 | -0.126 | -0.084 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0.848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 10.4 | 9.447 | 7.943 | 13.04 | 12.714 | 13.356 | 11.877 | 12.12 | 10.055 | 9.848 | 9.296 | 5.189 | 4.008 | 3.607 | 2.965 | 2.504 | 2.31 | 2.017 |
General & Administrative Expenses
| 5.592 | 5 | 5.87 | 6.911 | 7.078 | 6.999 | 6.895 | 8.13 | 7.76 | 6.93 | 7.292 | 2.53 | 2.279 | 1.398 | 0.734 | 0.475 | 0.577 | 0.542 |
Selling & Marketing Expenses
| 1.197 | 1.141 | 1.203 | 1.401 | 1.666 | 1.96 | 1.838 | 1.912 | 1.311 | 1.402 | 1.583 | 0.842 | 0.325 | 0.226 | 0.085 | 0.362 | 0.181 | 0.233 |
SG&A
| 6.789 | 6.141 | 7.073 | 8.312 | 8.744 | 8.959 | 8.733 | 10.042 | 9.071 | 8.332 | 8.875 | 3.372 | 2.604 | 1.624 | 0.819 | 0.837 | 0.758 | 0.775 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 17.189 | 15.588 | 15.016 | 21.352 | 21.458 | 22.315 | 20.61 | 22.162 | 19.126 | 18.18 | 18.171 | 8.561 | 6.612 | 5.231 | 3.784 | 3.341 | 3.068 | 2.792 |
Operating Income
| -17.713 | -16.109 | -15.541 | -21.352 | -21.458 | -22.315 | -20.61 | -22.162 | -19.126 | -18.18 | -18.171 | -8.561 | -6.612 | -5.231 | -3.784 | -3.341 | -3.068 | -2.792 |
Operating Income Ratio
| 0 | 0 | -4.505 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 2.508 | -0.892 | 2.43 | 5.648 | 5.081 | -4.607 | 9.43 | -2.575 | 17.601 | 60.707 | 88.262 | -56.887 | -0.026 | -1.658 | 0 | 0 | 0.021 | 0.089 |
Income Before Tax
| -15.205 | -17.001 | -13.111 | -15.704 | -15.334 | -26.922 | -11.18 | -24.737 | -1.453 | 42.527 | 70.08 | -65.479 | -6.638 | -5.231 | -3.784 | -3.341 | -3.047 | -2.703 |
Income Before Tax Ratio
| 0 | 0 | -3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0 | 0.478 | -4.148 | -0.447 | -1.043 | 5.638 | -8.709 | 3.038 | 0.029 | -60.728 | -59.972 | 56.887 | 0.026 | -1.657 | -0.001 | -0.001 | 0 | 0 |
Net Income
| -15.205 | -17.001 | -13.111 | -15.704 | -15.334 | -32.56 | -2.471 | -27.775 | -1.453 | 103.255 | 70.08 | -65.479 | -6.638 | -5.231 | -3.784 | -3.341 | -3.047 | -2.703 |
Net Income Ratio
| 0 | 0 | -3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -2.59 | -2.91 | -2.25 | -3.04 | -3.63 | -7.75 | -0.6 | -6.84 | -0.36 | 24.06 | 33.3 | -21.35 | -2.4 | -1.8 | -1.31 | -1.17 | -0.55 | -0.49 |
EPS Diluted
| -2.59 | -2.91 | -2.25 | -3.04 | -3.63 | -7.75 | -0.6 | -6.84 | -0.36 | 24.3 | 33.3 | -21.32 | -2.27 | -1.8 | -1.31 | -1.17 | -0.55 | -0.49 |
EBITDA
| -17.189 | -15.588 | -15.016 | -21.352 | -20.414 | -20.842 | -19.778 | -21.668 | -18.839 | -17.987 | -18.152 | -8.476 | -6.611 | -5.189 | -3.739 | -3.34 | -3.03 | -2.757 |
EBITDA Ratio
| 0 | 0 | -4.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |